BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. World J Gastroenterol 2012; 18(30): 3955-3961 [PMID: 22912546 DOI: 10.3748/wjg.v18.i30.3955]
URL: https://www.wjgnet.com/1007-9327/full/v18/i30/3955.htm
Number Citing Articles
1
José J. G. Marin, Maria Giuseppina Prete, Angela Lamarca, Simona Tavolari, Ana Landa-Magdalena, Giovanni Brandi, Oreste Segatto, Arndt Vogel, Rocío I. R. Macias, Pedro M. Rodrigues, Adelaida La Casta, Joachim Mertens, Cecilia M. P. Rodrigues, Maite G. Fernandez-Barrena, Ana Da Silva Ruivo, Marco Marzioni, Giulia Mentrasti, Pilar Acedo, Patricia Munoz-Garrido, Vincenzo Cardinale, Jesus M. Banales, Juan W. Valle, John Bridgewater, Chiara Braconi. Current and novel therapeutic opportunities for systemic therapy in biliary cancerBritish Journal of Cancer 2020; 123(7): 1047 doi: 10.1038/s41416-020-0987-3
2
Jose J.G. Marin, Oscar Briz, Elisa Herraez, Elisa Lozano, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Luis M. Osorio-Padilla, Ana I. Santos-Llamas, Maria A. Serrano, Carolina Armengol, Thomas Efferth, Rocio I.R. Macias. Molecular bases of the poor response of liver cancer to chemotherapyClinics and Research in Hepatology and Gastroenterology 2018; 42(3): 182 doi: 10.1016/j.clinre.2017.12.006
3
Laura Fouassier, Marco Marzioni, Marta B. Afonso, Steven Dooley, Kevin Gaston, Gianluigi Giannelli, Cecilia M. P. Rodrigues, Elisa Lozano, Serena Mancarella, Oreste Segatto, Javier Vaquero, Jose J. G. Marin, Cédric Coulouarn. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistanceLiver International 2019; 39(S1): 43 doi: 10.1111/liv.14102
4
Laura Taddia, Domenico D’Arca, Stefania Ferrari, Chiara Marraccini, Leda Severi, Glauco Ponterini, Yahuda G. Assaraf, Gaetano Marverti, Maria Paola Costi. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistanceDrug Resistance Updates 2015; 23: 20 doi: 10.1016/j.drup.2015.10.003
5
NICHAPAVEE NUTTHASIRIKUL, CHARIYA HAHNVAJANAWONG, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, CHANVIT LEELAYUWAT, SIRI CHAU-IN, PATCHAREE JEARANAIKOON. Targeting the Δ133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cellsInternational Journal of Oncology 2015; 47(6): 2153 doi: 10.3892/ijo.2015.3188
6
Kitti Intuyod, Paula Saavedra-García, Stefania Zona, Chun-Fui Lai, Yannasittha Jiramongkol, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Shang Yao, Jay-Sze Yong, Sasanan Trakansuebkul, Sakda Waraasawapati, Vor Luvira, Sopit Wongkham, Somchai Pinlaor, Eric W.-F. Lam. RETRACTED ARTICLE: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistanceCell Death & Disease 2018; 9(12) doi: 10.1038/s41419-018-1235-0
7
Jose J. G. Marin, Paula Sanchon-Sanchez, Candela Cives-Losada, Sofía del Carmen, Jesús M. González-Santiago, Maria J. Monte, Rocio I. R. Macias. Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of ResistanceCancers 2021; 13(10): 2358 doi: 10.3390/cancers13102358
8
Massimiliano Cadamuro, Simone Brivio, Carlo Spirli, Ruth Joplin, Mario Strazzabosco, Luca Fabris. Autocrine and Paracrine Mechanisms Promoting Chemoresistance in CholangiocarcinomaInternational Journal of Molecular Sciences 2017; 18(1): 149 doi: 10.3390/ijms18010149
9
Molin Wongwattanakul, Chariya Hahnvajanawong, Wunchana Seubwai, Chanvit Leelayuwat, Temduang Limpaiboon, Patcharee Jearanaikoon. Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopyJournal of Molecular Structure 2018; 1166: 416 doi: 10.1016/j.molstruc.2018.04.044
10
Keiichi Akahoshi, Daisuke Ban, Ryo Kuboki, Atsushi Oba, Hiroaki Ono, Yusuke Mitsunori, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Orotate phosphoribosyltransferase as a predictor of benefit from S‐1 adjuvant chemotherapy for cholangiocarcinoma patientsJournal of Gastroenterology and Hepatology 2019; 34(6): 1108 doi: 10.1111/jgh.14477
11
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
12
Shenli Zhang, Iain B. Tan, Nur S. Sapari, Heike I. Grabsch, Alicia Okines, Elizabeth C. Smyth, Toru Aoyama, Lindsay C. Hewitt, Imran Inam, Dan Bottomley, Matthew Nankivell, Sally P. Stenning, David Cunningham, Andrew Wotherspoon, Akira Tsuburaya, Takaki Yoshikawa, Richie Soong, Patrick Tan. Technical Reproducibility of Single-Nucleotide and Size-Based DNA Biomarker Assessment Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded TissuesThe Journal of Molecular Diagnostics 2015; 17(3): 242 doi: 10.1016/j.jmoldx.2014.12.001
13
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera Rizvi, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews Gastroenterology & Hepatology 2020; 17(9): 557 doi: 10.1038/s41575-020-0310-z
14
Rocio I.R. Macias, Jesus M. Banales, Bruno Sangro, Jordi Muntané, Matias A. Avila, Elisa Lozano, Maria J. Perugorria, Francisco J. Padillo, Luis Bujanda, Jose J.G. Marin. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1468 doi: 10.1016/j.bbadis.2017.08.002
15
Jose J.G. Marin, Elisa Lozano, Elisa Herraez, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Oscar Briz, Maria A. Serrano, Thomas Efferth, Rocio I.R. Macias. Chemoresistance and chemosensitization in cholangiocarcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1444 doi: 10.1016/j.bbadis.2017.06.005
16
Molin Wongwattanakul, Chariya Hahnvajanawong, Patcharaporn Tippayawat, Sirinart Chio-Srichan, Chanvit Leelayuwat, Temduang Limpaiboon, Patcharee Jearanaikoon, Philip Heraud. Classification of Gemcitabine resistant Cholangiocarcinoma cell lines using synchrotron FTIR microspectroscopyJournal of Biophotonics 2017; 10(3): 367 doi: 10.1002/jbio.201500253
17
Somphon Roeksomtawin, Panida Navasumrit, Somchamai Waraprasit, Varabhorn Parnlob, Thaniya Sricharunrat, Vajarabhongsa Bhudhisawasdi, Niramol Savaraj, Mathuros Ruchirawat. Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell linesOncology Letters 2018;  doi: 10.3892/ol.2018.8807